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Progression of Fatty Muscle Degeneration in
Atraumatic Rotator Cuff Tears
Jonah Hebert-Davies, MD, FRCSC, Sharlene A. Teefey, MD, Karen Steger-May, MA, Aaron M. Chamberlain, MD,
William Middleton, MD, Kathryn Robinson, MD, Ken Yamaguchi, MD, MBA, and Jay D. Keener, MD
Investigation performed at Washington University, St. Louis, Missouri

Background: The purpose of this prospective study was to examine the progression of fatty muscle degeneration over
time in asymptomatic shoulders with degenerative rotator cuff tears.
Methods: Subjects with an asymptomatic rotator cuff tear in 1 shoulder and pain due to rotator cuff disease in the
contralateral shoulder were enrolled in a prospective cohort. Subjects were followed annually with shoulder ultrasonography, which evaluated tear size, location, and fatty muscle degeneration. Tears that were either full-thickness at enrollment or progressed to a full-thickness defect during follow-up were examined. A minimum follow-up of 2 years was
necessary for eligibility.
Results: One hundred and ﬁfty-six shoulders with full-thickness rotator cuff tears were potentially eligible. Seventy
shoulders had measurable fatty muscle degeneration of at least 1 rotator cuff muscle at some time point. Patients with
fatty muscle degeneration in the shoulder were older than those without degeneration (mean, 65.8 years [95% conﬁdence
interval (CI), 64.0 to 67.6 years] compared with 61.0 years [95% CI, 59.1 to 62.9 years]; p < 0.05), and the median size of
the tears at baseline was larger in shoulders with degeneration than in shoulders that did not develop degeneration
(13 and 10 mm wide, respectively, and 13 and 10 mm long; p < 0.05). Tears with fatty muscle degeneration were more
likely to have enlarged during follow-up than were tears that never developed muscle degeneration (79% compared with
58%; odds ratio, 2.64 [95% CI, 1.29 to 5.39]; p < 0.05). Progression of fatty muscle degeneration occurred more
frequently in shoulders with tears that had enlarged (43%; 45 of 105) than in shoulders with tears that had not enlarged
(20%; 10 of 51; p < 0.05). Additionally, tears with enlargement and progression of muscle degeneration were more likely
to extend into the anterior supraspinatus than were those without progression (53% and 17%, respectively; p < 0.05);
however, this relationship was lost when controlling for tear size (p = 0.56). The median time from tear enlargement to
progression of fatty muscle degeneration was 1.0 year (range, 22.0 to 6.9 years) for the supraspinatus and 1.1 years
(range, 21.8 to 8.5 years) for the infraspinatus muscle (p = 0.98).
Conclusions: Progression of fatty muscle degeneration is more common in tears that are larger at baseline, enlarge over
time, and undergo a larger magnitude of enlargement. Our study ﬁndings also suggest that an often rapid progression of
muscle degeneration occurs in relation to a clinically relevant increase in tear size in some degenerative cuff tears.
Level of Evidence: Prognostic Level II. See Instructions for Authors for a complete description of levels of evidence.

Peer Review: This article was reviewed by the Editor-in-Chief and one Deputy Editor, and it underwent blinded review by two or more outside experts. It was also reviewed
by an expert in methodology and statistics. The Deputy Editor reviewed each revision of the article, and it underwent a ﬁnal review by the Editor-in-Chief prior to publication.
Final corrections and clariﬁcations occurred during one or more exchanges between the author(s) and copyeditors.

D

egenerative rotator cuff tears are at risk for the development of progressive muscle degeneration; however, the timeline and speciﬁc risks for progression are
ill-deﬁned1. Although the severity of fatty muscle2,3 inﬁltration

has important implications on the success of rotator cuff repairs,
little longitudinal information regarding the risks for progression of muscle degenerative changes is available. Currently,
surgical indications for rotator cuff treatment vary widely. The

Disclosure: The study was funded by the National Institutes of Health (R01 AR051026). On the Disclosure of Potential Conﬂicts of Interest forms, which
are provided with the online version of the article, one or more of the authors checked “yes” to indicate that the author had a relevant ﬁnancial relationship
in the biomedical arena outside the submitted work and “yes” to indicate that the author had other relationships or activities that could be perceived
to inﬂuence, or have the potential to inﬂuence, what was written in this work (http://links.lww.com/JBJS/D493).
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argument for early surgery is, generally, to intervene when the
likelihood of successful tendon healing is maximized. Several
studies have examined the factors associated with decreased
healing rates following cuff repair surgery. Among these, patient
age, tear size, and fatty inﬁltration have consistently been shown
to negatively impact healing 2,4-6. While previous studies have
examined the progression of tear size over time as well as the
association of fatty muscle inﬁltration in relation to tear size, to
our knowledge none have looked speciﬁcally at the temporal
progression of muscle degeneration1,7,8.
Rotator cuff tears are usually degenerative in nature and
affect a large number of patients, many of whom are asymptomatic1,9. Recent natural history studies have demonstrated
a time-dependent risk of tear enlargement1,10-12. Additionally,
studies have correlated tear enlargement with the development or progression of fatty muscle inﬁltration1,10,13. The
recent improved understanding of the natural history of degenerative rotator cuff disease has allowed clinicians to better
counsel patients regarding treatment options1,14. However, many
questions regarding progression of muscle degeneration remain unanswered. Fatty inﬁltration is associated with decreased healing and worse functional outcome following
rotator cuff repair15,16. Multiple studies have suggested that
muscle inﬁltration beyond grade 2, according to the Goutallier
classiﬁcation 17 , represents an inﬂection point at which
healing becomes less consistent2,4. Determining factors related to the development and timing of muscle degeneration
is potentially important for counseling patients with regard
to optimal surgical timing. Patients with asymptomatic degenerative rotator cuff tears represent an ideal cohort for
studying the natural history of rotator cuff muscle degeneration as treatment is unnecessary, given the absence of
clinical symptoms.
The primary purposes of this study were to examine the
rate of progression of fatty muscle degeneration in patients
with degenerative rotator cuff tears and to establish a temporal
proﬁle for this progression. Secondarily, we analyzed factors
associated with these changes to better identify higher-risk
tears. We hypothesized that progression of fatty muscle de-

P R O G R E S S I O N O F F AT T Y M U S C L E D E G E N E R AT I O N
R O TAT O R C U F F T E A R S

IN

A T R AU M AT I C

generation is more likely to occur in full-thickness tears that
enlarge than in stable tears.
Materials and Methods

I

nstitutional review board approval was obtained prior to study initiation.
This study represents a subanalysis of a cohort with degenerative rotator cuff
tears. Our cohort consisted of subjects with an asymptomatic full-thickness
rotator cuff tear, identiﬁed with an ultrasound examination, who presented for
evaluation of pain in the contralateral shoulder due to rotator cuff disease.
Exclusion criteria included any past or current pain in the asymptomatic shoulder,
trauma to the asymptomatic shoulder, inﬂammatory arthritis, radiographic evidence of osteoarthritis in the asymptomatic shoulder, upper-extremity weightbearing demands, and the presence of a massive rotator cuff tear or grade-IV
fatty muscle degeneration (using a previously validated measurement tool
18,19
described in Table I
).
Each subject was evaluated at baseline and annually thereafter for assessment of pain and shoulder function, and underwent shoulder ultrasonography to determine speciﬁc rotator cuff tear and muscle characteristics. This
analysis was speciﬁcally related to ultrasound data regarding tear size and the
presence or progression of fatty muscle degeneration. Because previous work
8
has shown muscle degeneration to be almost exclusive to full-thickness tears ,
we included only tears that were full-thickness at baseline or progressed to
full-thickness during follow-up. We required a minimum of 2 years of followup for all tears, either from the time of enrollment or after conversion to a fullthickness tear. A measurable tear size and a conﬁrmatory subsequent annual
ultrasound evaluation after a tear enlargement event occurred were required for
inclusion in this study. Additionally, for partial-thickness tears progressing to
full-thickness tears, we included only those tears with ultrasound assessment
of muscle degeneration prior to and following full-thickness progression.
Each subject underwent a standardized shoulder ultrasound (see Appendix). Tear dimensions were reviewed annually, and enlargement was deﬁned
as an increase in size of ‡5 mm in any direction compared with baseline for
full-thickness tears and conversion to a full-thickness defect for partial tears.
Fatty degeneration of the rotator cuff was evaluated using the echogenicity and
architecture of the supraspinatus and infraspinatus muscles, and each was
18,19
graded with a previously validated, modiﬁed 3-point scale
. Both tear size
and echogenicity were evaluated by the same radiologist. The evaluators were
blinded to previous measurements. The echogenicity was graded in comparison
with overlying muscle (the trapezius for the supraspinatus and the deltoid
for the infraspinatus) (Table I).

Statistical Analysis
Patient demographics and follow-up length were compared for subjects with
and without muscle degeneration using the unpaired t test (for normally

TABLE I Classiﬁcation of Rotator Cuff Muscle Degeneration by Ultrasound Examination*
Grade†

Echogenicity‡

Architecture

0

Isoechoic to the overlying muscle

Clearly visible intramuscular tendons and identiﬁable
muscle pennate pattern

1

Slightly increased echogenicity compared with the overlying muscle

Partially visible intramuscular tendons and muscle
pennate pattern

2

Markedly increased echogenicity compared with the overlying muscle

No discernible tendons or muscle pennate pattern

*Reproduced from: Wall LB, Teefey SA, Middleton WD, Dahiya N, Steger-May K, Kim HM, Wessell D, Yamaguchi K. Diagnostic performance and
reliability of ultrasonography for fatty degeneration of the rotator cuff muscles. J Bone Joint Surg Am. 2012 Jun 20;94(12):e83. †Total grade is
formed from adding the scores of both echogenicity (0-1-2) and architecture (0-1-2) to create a combined grade from 0 to 4. ‡The trapezius was
used as a reference for determining the echogenicity of the supraspinatus, and the deltoid was used as the reference for determining the
echogenicity of the infraspinatus and teres minor.
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distributed variables), the Wilcoxon test (for non-normally distributed variables), or the chi-square test (for categorical variables).
The occurrence of tear enlargement for subjects with and without
muscle degeneration progression was compared using logistic regression with
enlargement as the dependent variable and muscle progression as the independent variable. The age of the patient at the time of study enrollment,
dominant study side, sex, and tear width at the ﬁrst visit as a full-thickness tear
were included as covariates. Hand dominance in the study side was included
as a covariate as previous research from this cohort demonstrated a higher
1
risk of tear enlargement in the dominant shoulder .
For tears with enlargement, baseline tear size and change in tear dimensions were compared for shoulders with and without muscle degeneration
20
progression using nonparametric analysis of covariance in which the tear size
was the dependent variable, muscle degeneration status (presence or absence)
was the independent variable, and age, sex, and dominant study side were
covariates. Logistic regression with age, sex, baseline tear size (width), and
dominant study side as covariates compared the proportion of subjects with
anterior supraspinatus involvement for shoulders with and without muscle
degeneration progression.
Tears with progression of fatty muscle degeneration were classiﬁed
by the muscle that underwent progression. If muscle degeneration progression occurred in both muscles, the tear was classiﬁed as undergoing
progression in each muscle and, therefore, contributed nonindependent
data for each muscle. To account for the lack of independence, the time
between tear enlargement and muscle degeneration progression was compared for tears with progression of the supraspinatus and tears with progression of the infraspinatus, using generalized estimating equations with a
normal distribution, identity link function, and unstructured correlation

P R O G R E S S I O N O F F AT T Y M U S C L E D E G E N E R AT I O N
R O TAT O R C U F F T E A R S

IN

A T R AU M AT I C

among nonindependent observations. This comparison was repeated for
tears with progression of muscle degeneration in a single muscle (i.e., tears
with progression in both muscles were excluded) using the Wilcoxon
2-sample test.
A post hoc power analysis was performed to examine the relationship of
tear enlargement and the progression of fatty muscle degeneration (a demonstrated p value of 0.01). With a sample size of 51 subjects without and 105
subjects with tear enlargement, the study had 85% statistical power to detect
the observed difference in muscle degeneration progression of 23.3% using a
2-tailed t test at alpha = 0.05. The study had 80% statistical power to detect
a difference of 21.7% between groups.

Results
Demographics
f the 188 shoulders with a full-thickness tear during surveillance and a minimum follow-up of 2 years, a total of 156 tears met our inclusion and exclusion criteria
and were included in the analysis. Twenty-eight shoulders
were excluded because of a lack of annual ultrasound evaluation, preventing speciﬁc temporal data from being interpreted. Four other shoulders were excluded from analysis
because of grade-4 muscle degeneration of either the supraspinatus or infraspinatus muscles at baseline, thus preventing analysis of progression. Eighty-six of these tears
had no fatty degeneration of either the supraspinatus or
infraspinatus muscles at any point during surveillance. The

O

TABLE II Patient Demographics and Length of Follow-up Compared with Muscle Degeneration
Muscle Degeneration at Any Study Time Point
Variable Description

Entire Cohort (N = 156)

Absent (N = 86)

Present (N = 70)

P Value

63.2 (8.7)
63.6 (8.5)

61.0 (9.0)
61.4 (8.7)

65.8 (7.7)
66.4 (7.5)

0.0005*
0.0002*

From study enrollment to most recent visit

6.0 (5.1)

5.9 (5.5)

6.2 (4.7)

0.14‡

From 1st visit as full-thickness tear to most
recent visit

4.2 (5.4)

4.2 (5.1)

5.0 (5.2)

0.16‡

Mean age (and standard deviation) (yr)
At time of study enrollment
At time of 1st visit as full-thickness tear
Study duration† (yr)

Sex§ (no.)

0.04#

Male

96 (62%)

59 (69%)

37 (53%)

Female

60 (38%)

27 (31%)

33 (47%)

Tear at 1st visit as full-thickness tear† (mm)
Width

10.0 (9.0)

10.0 (5.0)

13.0 (12.0)

0.0002‡

Length

11.0 (9.0)

10.0 (6.0)

13.0 (15.5)

0.0001‡

105 (67%)

50 (58%)

55 (79%)

51 (33%)

36 (42%)

15 (21%)

Tear enlargement during study period (no.)
Yes
No
Time from tear enlargement to most recent
follow-up† (yr)

0.007#

2.0 (2.9)

1.9 (4.0)

2.2 (2.7)

0.22‡

*P value is for the comparison of the absence and presence of muscle atrophy by the unpaired t test. †The values are given as the median, with
the interquartile range (calculated as the 75th percentile minus the 25th percentile) in parentheses. ‡P value is for the comparison of the absence
and presence of muscle atrophy by the Wilcoxon 2-sample test. §The values are given as the number of subjects with usable measurements.
#P value is for the comparison of the proportion of patients with and without muscle atrophy with the chi-square test.
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TABLE III Muscle Degeneration Data by Tear Enlargement at Any Time During the Study Period
Tears with No Enlargement
During Study Period (N = 51)

Tears with Enlargement
During Study Period (N = 105)

No progression

41 (80%)

60 (57%)

Progression

10 (20%)

45 (43%)

Infraspinatus only
Supraspinatus only

3 (30%)
2 (20%)

11 (24%)
12 (27%)

Both infraspinatus and supraspinatus

5 (50%)

22 (49%)

Variable
Progression of muscle degeneration (no.)

P Value*
0.003

Patients with progression of muscle degeneration† (no.)

0.87

*P value is for comparison of the proportion of patients in each group for tears that did not enlarge and those with tears that did enlarge by logistic
regression with the following covariates: age at study enrollment, dominant study side, sex, and tear width at 1st visit as full-thickness tear. †Ten
patients had progression of muscle degeneration with no enlargement, and 45 had tears with enlargement during study period.

remaining 70 shoulders had measurable degeneration of
1 or both muscles.
The median duration of follow-up was 6.0 years from
enrollment (Table II). Patients with fatty muscle degeneration
of the shoulder at any time point were older (mean, 65.8 years;
95% conﬁdence interval [CI], 64.0 to 67.6 years) than patients
without degeneration (61.0 years; 95% CI, 59.1 to 62.9 years;

p < 0.05). The prevalence of fatty degeneration was greater in
women than in men (p < 0.05). There was no difference in
follow-up length between shoulders with and without fatty
muscle degeneration (p = 0.14). The median size of the tears at
baseline was larger for those with fatty muscle degeneration
than for those without degeneration (13.0 versus 10.0 mm in
width [p < 0.05] and 13.0 versus 10.0 mm in depth [p < 0.05]).

TABLE IV Statistical Comparisons of Characteristics by Muscle Degeneration Progression for Patients with Tear Enlargement
Tear Enlargement by Muscle Degeneration
Progression
Variable Description

Enlargement without
Progression (N = 60)

Enlargement with
Progression (N = 45)

P Value

Tear size at 1st full-thickness measurement* (mm)
Width

10.0 (5.0)

15.0 (12.0)

0.0002†

Length

10.0 (5.0)‡

13.0 (17.0)

0.003†

Anterior supraspinatus tendon involvement at 1st
full-thickness measurement§ (no.)
Spared
Disrupted

0.56#
38 (83%)

14 (47%)

8 (17%)

16 (53%)

Change in tear size from 1st full-thickness measurement to
enlargement event* (mm)
Width**

5.0 (7.0)

9.0 (8.5)

0.009††

Length‡‡

6.0 (7.0)

6.0 (9.5)

0.39††

*The values are given as the median, with the interquartile range in parentheses. †Because of non-normal data distributions for the outcome
variable, the p value is for the comparison of tears with no muscle degeneration progression and those with progression by nonparametric
covariance analysis with age at study enrollment, dominant study side, and sex as covariates. ‡Data were available for only 59 tears. §Data are for
46 tears of the anterior supraspinatus tendon that had enlargement without progression and for 30 tears that had enlargement with progression.
#P value is for the comparison of the proportion of involved anterior supraspinatus for tears with no muscle degeneration progression and those
with progression by logistic regression with the following covariates: age at study enrollment, dominant study side, sex, and tear width at 1st visit
as full-thickness tear. **Data on width were available for 57 tears that had enlargement without progression and for 44 tears that had enlargement with progression. ††Because of the non-normal data distributions for the outcome variable, the p value is for the comparison of tears
with no muscle degeneration progression and those with progression by nonparametric covariance analysis with the following covariates: age at
study enrollment, dominant study side, sex, and the value of the outcome variable at the 1st visit as full-thickness (i.e., tear width and tear length,
respectively). ‡‡Data on the length were available for 57 tears that had enlargement without progression and for 40 tears that had enlargement
with progression.
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Muscle Degeneration and Tear Enlargement
Of the 156 full-thickness tears, 105 (67%) enlarged at least
5 mm (width, length, or both) during follow-up (Table II). The
median period of follow-up from the time a tear was identiﬁed
as full-thickness to tear enlargement was 2.0 years. The tears
that had fatty muscle degeneration of any grade (at any time
point) were more likely to have had an increase in tear size
during follow-up (79% [55 of 70]) than were tears that never
developed muscle degeneration (58% [50 of 86]); the difference was signiﬁcant (p < 0.05) (odds ratio [OR] = 2.64; 95%
CI, 1.29 to 5.39).
Fifty-ﬁve (79%) of the 70 shoulders with fatty muscle
degeneration demonstrated progression of degeneration during follow-up (see Appendix). Of the 105 tears that enlarged, 60
had no progression of fatty muscle degeneration and 45 had
progression. Subjects with tear enlargement and fatty muscle
degeneration progression were older at the time of enrollment
(mean, 66.0 years) than were those with no progression (mean,
61.6 years); the difference was signiﬁcant (p < 0.05) (Table II).
Accounting for age, sex, and study side dominance as covariates, the tears with enlargement and progression of fatty
muscle degeneration had a larger initial tear width (median,
15.0 versus 10.0 mm) and length (median, 13.0 versus 10.0 mm)
(p < 0.05 for both) than did the tears that enlarged but had
no increase in muscle degeneration. Accounting for covariates, tears that enlarged were more likely to demonstrate
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progression of fatty muscle degeneration (43%; 45 of 105)
than were shoulders without enlargement of tears (20%; 10
of 51); the difference was signiﬁcant (p < 0.05) (Table III).
Additionally, tears with enlargement and progression of fatty
muscle degeneration were more likely to involve the anterior
supraspinatus than were those without muscle degeneration
progression (53% versus 17%); however, this did not reach
signiﬁcance when accounting for tear size (p = 0.56) (Table
IV). The magnitude of width enlargement for tears with
progression of fatty muscle degeneration (median, 9.0 mm)
was larger than that for tears without progression (median,
5.0 mm); the difference was signiﬁcant (p < 0.05). However,
there was no difference in the change in tear length (retraction) between groups (median, 6.0 mm in each group)
(p = 0.39).
Temporal Progression of Muscle Degeneration
The temporal relationship of the ﬁrst tear enlargement and
progression of fatty muscle degeneration was examined in the
45 shoulders in which both occurred (Table V). Progression of
fatty muscle degeneration occurred in both the supraspinatus
and infraspinatus in 22 shoulders, while isolated progression
was seen in the supraspinatus in 12 shoulders and in the infraspinatus in 11 shoulders (Table III). For the supraspinatus,
fatty muscle degeneration progression occurred after enlargement (median, 2.0 years) in 21 shoulders (62%). Six shoulders

TABLE V Analysis of Temporal Relationship of Tear Enlargement and Progression of Muscle Degeneration

Variable Description
Using 1st tear enlargement event
Progression of muscle degeneration
after tear enlargement

No.

Time from Tear Enlargement
to Progression of Muscle
Degeneration in
Supraspinatus* (yr)

No.

Time from Tear
Enlargement to Progression
of Muscle Degeneration in
Infraspinatus* (yr)

NA
21

2.0 (1.8; 0.6 to 6.9)

20

3.1 (2.6; 0.6 to 8.5)

Simultaneous progression of muscle
degeneration and enlargement

6

0.0 (0.0)

7

0.0 (0.0)

Progression of muscle degeneration
before tear enlargement

7

1.0 (1.0; 0.5 to 2.0)

6

0.9 (0.4; 0.5 to 1.8)

No progression of degeneration in the
speciﬁc muscle

P Value†

11

NA

12

NA

34

1.0 (2.1; 22.0 to 6.9)

33

1.1 (3.2; 21.8 to 8.5)

0.98§

12

1.4 (2.6; 22.0 to 4.6)

11

3.1 (4.9; 0.0 to 5.4)

0.10#

Muscle‡
All tears with progression of muscle
degeneration and tear enlargement
Tears with progression of degeneration
in a single muscle and enlargement

*The values are given as the median, with the interquartile range and the minimum and maximum measurements in parentheses. NA = not
applicable. Progression was deﬁned for each muscle separately. Tears with progression of the supraspinatus only or both the supraspinatus and
infraspinatus were classiﬁed as having supraspinatus progression. Tears with progression of the infraspinatus only or both the supraspinatus and
infraspinatus were classiﬁed as having infraspinatus progression. †NA = not applicable. ‡Tears with muscle degeneration progression before the
1st tear enlargement are reported with a negative time. Tears with muscle degeneration progression after the 1st tear enlargement are reported
with a positive time. Tears with simultaneous progression of muscle degeneration and 1st tear enlargement are reported with a zero time. §P
value is for the comparison of the supraspinatus and the infraspinatus muscle by generalized estimating equations. #P value is for the comparison
of the supraspinatus and the infraspinatus muscle according to the Wilcoxon 2-sample test.
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had concurrent tear enlargement and muscle progression, and
7 shoulders had muscle progression prior to enlargement
(median, 1.0 year). For the infraspinatus, progression of fatty
muscle degeneration occurred after enlargement (median, 3.1
years) in 20 shoulders (61%). Seven shoulders had simultaneous tear enlargement and muscle progression, and 6 shoulders had muscle progression prior to enlargement (median, 0.9
year). The median time for fatty muscle progression was 1.0
year for tears involving the supraspinatus and 1.1 years for
those involving the infraspinatus (p = 0.98). For tears with
progression of fatty muscle degeneration occurring in a single
muscle only, the median time from enlargement to progression
was 1.4 years for the supraspinatus compared with 3.1 years for
the infraspinatus (p = 0.10).
Discussion
he present study demonstrates important associations
between the temporal progression of fatty muscle degeneration and rotator cuff tear enlargement and is the ﬁrst,
to our knowledge, to do so using rigorous prospective evaluation. Speciﬁc factors related to the progression of fatty
muscle degeneration include a larger baseline tear size, interval tear enlargement, and larger magnitudes of tear enlargement. Fatty muscle degeneration of the rotator cuff is
clinically relevant, given a known detrimental relationship of
advanced fatty inﬁltration on healing rates and functional
outcomes and given that fatty changes do not regress
following cuff repair surgery 9,21,22. Our study results reinforce
and clarify several notions about fatty muscle degeneration in
atraumatic rotator cuff tears. The presence of fatty muscle
degeneration is more common in larger tears and in older
patients23,24, and progression is more frequent with tear
enlargement1,13.
The relatively small size of the tears in this study, a mean
tear width between 10 and 15 mm, may account for the
modest prevalence of muscle degeneration (45%) in this cohort. Previous studies have shown that tear size and location
are determining factors in the development of muscle inﬁltration and degeneration8,21,23,25,26. Nakagaki et al. reported that
larger tear size was associated with greater muscle inﬁltration
in cadavers27. Rulewicz et al. found a similar correlation for
the supraspinatus on magnetic resonance imaging (MRI)
evaluation21. Another study found that muscle inﬁltration
correlated with increased age and larger tear size26. Previous
analysis of the present cohort demonstrated that tear size was
the most important predictor of infraspinatus fatty muscle
degeneration, while anterior supraspinatus tendon integrity
was most strongly correlated with supraspinatus fatty muscle
degeneration8.
This prospective analysis of rotator cuff tear enlargement and fatty muscle degeneration revealed several clinically relevant ﬁndings. Notably, tear enlargement is a risk
factor for progression of muscle degeneration independent
of the effect of age. Fatty muscle degeneration advanced at
least 2 grades in many shoulders, which is likely clinically
relevant. Several natural history studies have also shown a
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link between tear enlargement and advancing fatty muscle
inﬁltration or degeneration1,11,25. Our data showed that tears
with progressive fatty muscle degeneration were initially
larger than tears that enlarged without progressive muscle
changes. Tears of approximately 15 mm in width that continue to enlarge appear to be at higher risk for advancing
fatty muscle degeneration. Lastly, the magnitude of tear
enlargement may be important for muscle degeneration,
speciﬁcally, the tear width (size) as opposed to retraction.
Progressive fatty muscle degeneration was more commonly
seen in tears that enlarged approximately 1 cm compared
with enlargement of 5 mm. Collectively, our study results
suggest that tears that are larger than 1 cm and enlarge ‡1 cm
are at higher risk for fatty muscle degeneration progression
than are smaller tears that are stable or minimally enlarged.
The rotator cable has been theorized to have a stressshielding effect, maintaining the force couple in tears isolated
within the rotator crescent28. The anterior aspect of the supraspinatus tendon is the strongest region of the tendon29, and
studies have shown increased gapping and strain in tears involving the rotator cable compared with isolated crescent
tears30. Previous research has demonstrated the importance of
the anterior aspect of the supraspinatus tendon (anterior cable)
in preserving the health of both of the supraspinatus and infraspinatus muscles1,10. Kim et al. demonstrated that tears not
involving the anterior aspect of the supraspinatus are 96% less
likely to have fatty muscle degeneration7. In our series, tear
enlargement involving the anterior aspect of the supraspinatus had a threefold greater risk of fatty muscle degeneration
progression compared with tears that enlarged but spared
the anterior aspect of the supraspinatus. However, when
accounting for tear size as a covariate, this relationship failed
to reach signiﬁcance. This conﬁrms the ﬁnding of a previous
study of this cohort that showed that tears with disruption
of the anterior aspect of the supraspinatus are larger than
tears isolated to the rotator crescent (19.0 compared with
10.0 mm)31.
Our prospective study design allowed a novel analysis of
the temporal relationship of fatty muscle degeneration progression compared with tear enlargement. For most tears,
the development or progression of fatty muscle degeneration
occurred after an enlargement event. However, in approximately 20% of tears with both enlargement and progression,
progression of muscle degeneration occurred prior to enlargement, with another 20% demonstrating simultaneous
enlargement and muscle deterioration. The time to progression of fatty muscle degeneration averaged approximately
1 year after enlargement for both the supraspinatus and infraspinatus muscles when examining the groups as a whole.
Since this cohort consists of atraumatic degenerative cuff tears
and we captured shoulders in varying stages of disease, we
recognize that it is arbitrary to designate 1 enlargement event
as a baseline. However, we believe our ﬁndings to be clinically
relevant, highlighting the fact that progression of fatty muscle
degeneration may occur in a close timeline to tear enlargement. Melis et al. were the ﬁrst to examine the temporal
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nature of fatty inﬁltration of the supraspinatus and infraspinatus from the onset of symptoms23,24. They concluded that
muscle inﬁltration occurred 3 years after pain development in
the supraspinatus and 2.5 years after for the infraspinatus.
Their ﬁndings are somewhat limited by retrospective analysis,
potential recall bias for the onset of pain, and the heterogeneity (both traumatic and atraumatic) of tears.
Our study has several limitations. There are missing data
regarding fatty muscle degeneration in some subjects, as the
collection of fatty muscle degeneration data began only after
ultrasound ﬁndings were validated with MRI ﬁndings19. Another limitation is the unknown chronicity of the tears at enrollment. Given that tears in this cohort are degenerative and
asymptomatic, the age of most tears is unknown. This makes it
difﬁcult to ascertain the exact temporal relationship between
tear enlargement and the onset of muscle degeneration. This
limitation is partially overcome by deﬁning a clinically important tear enlargement event and then following potential
muscle changes over a longer period; in this study, follow-up
was 6 years. The relatively small number of shoulders analyzed
(n = 45) for the temporal relationship of enlargement to progression of fatty muscle degeneration certainly limits deﬁnitive
conclusions regarding this relationship. The classiﬁcation system for this study is based on ultrasound evaluation rather than
computed tomography (CT) scanning or MRI, which are more
commonly utilized grading systems. Although ultrasonography
has been validated against MRI for assessing cuff muscle degenerative changes, the ultrasound grading system has not been
correlated to surgical outcomes. Additionally, it should be
noted that both CT scan and MRI assess fatty inﬁltration,
whereas ultrasonography is a measure of both fatty inﬁltration
and muscle architectural changes (degeneration). Lastly, our study
ﬁndings pertain to subjects with bilateral degenerative cuff tears
and may not be directly comparable with other studies that may
include a more heterogeneous population of rotator cuff tears.
In conclusion, this prospective analysis of asymptomatic
degenerative rotator cuff tears revealed several clinically relevant ﬁndings. Progression of fatty muscle degeneration is more
common in tears that are larger at baseline, in tears that enlarge
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over time, and in tears with a larger magnitude of enlargement.
Although the integrity of the anterior supraspinatus tendon is
important for the preservation of muscle health, the effect of
anterior cable integrity on muscle changes is more reﬂective
of the larger tear sizes seen in cable-disrupted tears. Our study
ﬁndings also suggest an often rapid progression of fatty muscle
degeneration in relation to a clinically relevant increase in tear
size in some degenerative cuff tears. Active surveillance or early
surgical intervention should be considered for painful tears
with these risk factors.
Appendix
A description of the shoulder ultrasonography protocol
for tear dimensions and location (including references 32,
33, and 34, which are cited only in the Appendix) and a table
with data on the magnitude of rotator cuff muscle degeneration
progression during follow-up are available with the online
version of this article as a data supplement at jbjs.org (http://
links.lww.com/JBJS/C848). n
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